Plasma and tissue disposition of non-liposomal DB-67 and liposomal DB-67 in C.B-17 SCID mice.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 5, p. 399
- By:
- Publication type:
- Article
Works matching IS 01676997 AND DT 2008 AND VI 26 AND IP 5
Results: 10
1
2
A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable?
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 5, p. 463, doi. 10.1007/s10637-008-9127-2
- By:
- Publication type:
- Article
3
Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 5, p. 407
- By:
- Publication type:
- Article
4
Effect of coadministration of ketoconazole, a strong CYP3A4 inhibitor, on pharmacokinetics and tolerability of motesanib diphosphate (AMG 706) in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 5, p. 455, doi. 10.1007/s10637-008-9144-1
- By:
- Publication type:
- Article
5
Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 5, p. 483, doi. 10.1007/s10637-008-9131-6
- By:
- Publication type:
- Article
6
Synthesis and in vitro antiproliferative activity against human cancer cell lines of novel 5-(4-methyl-benzylidene)-thiazolidine-2,4-diones.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 5, p. 437, doi. 10.1007/s10637-008-9130-7
- By:
- Publication type:
- Article
7
Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 5, p. 445, doi. 10.1007/s10637-008-9142-3
- By:
- Publication type:
- Article
8
Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by a new series of substituted-1,3,4-oxadiazole derivatives.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 5, p. 425, doi. 10.1007/s10637-008-9116-5
- By:
- Publication type:
- Article
9
Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinoma.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 5, p. 473
- By:
- Publication type:
- Article
10
Inhibitory effects of quercetin derivatives on phosphodiesterase isozymes and high-affinity [<sup>3</sup> H ]-rolipram binding in guinea pig tissues.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 5, p. 417, doi. 10.1007/s10637-008-9114-7
- By:
- Publication type:
- Article